Community voting is open to everyone. Members vote once per account, qualify for prizes, and see a members-only tally that is a cleaner signal.
Probiful
Log inSign up
Pricing
Will Humira WAC be below $60,000/year by Dec 31, 2026?
Odds
Yes70%
Market details
Status
void
Positions
1
Volume
50 cr
Locks
Feb 12, 2026
Updated
Dec 20, 2025, 04:00 PM
Rules summary
Resolves YES if Humira (adalimumab) US WAC annualized price is < $60,000/year as of Dec 31, 2026. Primary source: sponsor WAC/list price publication or a clearly cited WAC source. Otherwise NO.
View full rulesv1
Market context
Biosimilar-tagged example for filtering and recommendation overlap behavior.
People are also buying
Browse
ET-600 (desmopressin oral solution) monthly WAC at launch?
70% yes50 vol
Research
0 comments
Log in to comment.
No comments yet.
Community vote50% Yes · 0 votes
VoteVoting closed